The analysts forecast the global orthobiologics market to grow at a CAGR of 7.01% during the period 2018-2022.
Orthobiologics are made with substances found naturally in the human body and are used for treating orthopaedic diseases. They are used for swift healing, faster recovery, and fewer hospital visits.
The report covers the present scenario and the growth prospects of the global orthobiologics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the use of bone graft substitutes, visco supplementation, and stem cells across application segments including spinal fusion, reconstructive surgery, and trauma repair.
The latest trend gaining momentum in the market is the increase in development of new products. These product launches will encourage vendors to invest in developing advanced products to maintain their position in the market.
One of the major drivers for this market is the rise in approvals and clearances for orthobiologics products. The global orthobiologics market is witnessing a number of ongoing R&D projects for the manufacture of orthobiologics.
The report states that one of the major factors hindering the growth of this market is the high costs and inadequate reimbursements for orthobiologics products and procedures. The high pricing of orthobiologics products and procedures is one of the major challenges for the growth of the global orthobiologics market.
- Johnson & Johnson Services
Key Topics Covered:
1: Executive Summary
2: Scope Of The Report
3: Research Methodology
4: Market Landscape
5: Market Sizing
6: Five Forces Analysis
7: Market Segmentation By Product
8: Market Segmentation By Application
9: Customer Landscape
10: Regional Landscape
11: Decision Framework
12: Drivers And Challenges
13: Market Trends
14: Vendor Landscape
15: Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/rppr2s/global?w=4